Heterogeneous Presentations of iMCD: A Single‐Institution Case Series
These cases highlight the heterogeneity and challenging diagnosis of this rare cytokine-driven hematological disorder and the role of siltuximab in the treatment of iMCD.
Authors
- Anthony Sisk (ORCID: https://orcid.org/0000-0001-7262-3985)
- Jonathan E. Zuckerman (ORCID: https://orcid.org/0000-0001-9758-2147)
- Jaspreet Kaur (ORCID: https://orcid.org/0000-0002-4125-5355)
- Haifaa Abdulhaq (ORCID: https://orcid.org/0000-0002-3549-0981)
Institutions
- University of California, Los Angeles (US)
- University of California, San Francisco (US)
- California State University, Fresno (US)
Publication Details
- Journal
- Case Reports in Hematology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1155/crh/3377688
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Recordati Rare Diseases